BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33885714)

  • 1. IL-9 in CLL: sensing home and settling down!
    Ringshausen I
    Blood; 2021 Apr; 137(16):2130-2131. PubMed ID: 33885714
    [No Abstract]   [Full Text] [Related]  

  • 2. Proliferation of B cells from chronic lymphocytic leukemia is selectively promoted by B cell growth factor.
    Alvarez-Mon M; de la Hera A; Gaspar ML; Orfao A; Casas J; Jordá J; Durantez A
    Acta Haematol; 1989; 81(2):91-7. PubMed ID: 2496557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
    Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
    Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
    Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
    Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.
    Schuler M; Tretter T; Schneller F; Huber C; Peschel C
    Immunobiology; 1999 Feb; 200(1):128-39. PubMed ID: 10084701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 1 (IL-1 alpha and IL-1 beta) induces differentiation/activation of B cell chronic lymphoid leukemia cells.
    Takeuchi H; Katayama I
    Cytokine; 1994 May; 6(3):243-6. PubMed ID: 8054479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
    Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
    Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the mechanism underlying antitumor effect of interleukin 27 on B cells of chronic lymphocytic leukemia patients.
    Manouchehri-Doulabi E; Abbaspour S; Rostami S; Faranoush M; Ghahramanfard F; Pak F; Barati M; Kokhaei P; Momtazi-Borojeni AA
    J Cell Physiol; 2020 Dec; 235(12):9424-9431. PubMed ID: 32383245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
    Spaner DE; Hammond C; Mena J; Shi Y
    Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells.
    Jurlander J; Lai CF; Tan J; Chou CC; Geisler CH; Schriber J; Blumenson LE; Narula SK; Baumann H; Caligiuri MA
    Blood; 1997 Jun; 89(11):4146-52. PubMed ID: 9166857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
    Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
    Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
    Defrance T; Vanbervliet B; Durand I; Banchereau J
    Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia cells induce non-T cells to produce IgE in the presence of interleukin-4.
    Nüsslein HG; Dietz A; Burger R; Träg T; Kalden JR; Gramatzki M
    J Clin Immunol; 1993 Nov; 13(6):397-405. PubMed ID: 8288724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell chronic lymphocytic leukaemia populations respond stochastically to combinations of growth signals in vitro.
    McManus AP; Desai ZR; Lavabre-Bertrand T
    Leuk Res; 1993 Jun; 17(6):477-81. PubMed ID: 8505846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21.
    Hagn M; Blackwell SE; Beyer T; Ebel V; Fabricius D; Lindner S; Stilgenbauer S; Simmet T; Tam C; Neeson P; Trapani JA; Schrezenmeier H; Weiner GJ; Jahrsdörfer B
    Int Immunol; 2014 Jul; 26(7):383-95. PubMed ID: 24497611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression.
    Sainz-Perez A; Gary-Gouy H; Gaudin F; Maarof G; Marfaing-Koka A; de Revel T; Dalloul A
    J Immunol; 2008 Nov; 181(9):6051-60. PubMed ID: 18941194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells.
    Pascutti MF; Jak M; Tromp JM; Derks IA; Remmerswaal EB; Thijssen R; van Attekum MH; van Bochove GG; Luijks DM; Pals ST; van Lier RA; Kater AP; van Oers MH; Eldering E
    Blood; 2013 Oct; 122(17):3010-9. PubMed ID: 24014238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
    Büssing A; Stein GM; Stumpf C; Schietzel M
    Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogenous response of B cell chronic lymphocytic leukaemia (B-CLL) cells to anti-human IgM antibody (anti-mu) and B cell stimulatory factor 1 (BSF-1).
    Kawano M; Iwato K; Asaoku H; Tanabe O; Tanaka H; Ishikawa H; Imamura N; Kuramoto A
    Br J Haematol; 1989 Jan; 71(1):47-51. PubMed ID: 2492819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.